Sponsor:
Astellas Pharma Global Development, Inc.
Code:
NCT04729114
Conditions
Prostate Cancer
Metastatic Castration Resistant Prostate Cancer
Metastatic Castration-sensitive Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PRL-02 injection
prednisone
dexamethasone
enzalutamide
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Astellas Pharma Global Development, Inc. on 2025-03-20.